APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT05186012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

NHL, Adult

Interventions

DRUG: APG-1252
DRUG: Chidamide

Sponsor

Ascentage Pharma Group Inc.